Selective Cytotoxicity of Manganese Nanoparticles against Human Glioblastoma Cells


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Toxicity of different types of manganese nanoparticles against glioblastoma U-87MG and U-251 cells and normal human cells was studied using MTT test. The selectivity of the toxic effect of nanoparticles was evaluated as the ratio of 50% cytotoxic concentration (СС50) for human embryos fibroblasts (FECh-15) to their СС50 for tumor cells. Five of 6 samples of tested nanoparticles demonstrated selective toxic effect in vitro. Manganese oxide nanoparticles were characterized by maximum selectivity (СС50 6.9 nM and 2.1 nM for U-87MG and U-251 cells, respectively): selectivity index for glioblastoma U-87MG and U-251 cells was 29 and 95.2, respectively. Manganese oxide nanoparticles used for MRI detection of gliomas can be used for designing an oncolytic agent for the treatment of glial tumors in humans.

Об авторах

I. Razumov

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Автор, ответственный за переписку.
Email: razumov@bionet.nsc.ru
Россия, Novosibirsk

E. Zav’yalov

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: razumov@bionet.nsc.ru
Россия, Novosibirsk

S. Troitskii

G. K. Boreskov Institute of Catalysis, Siberian Division of the Russian Academy of Sciences

Email: razumov@bionet.nsc.ru
Россия, Novosibirsk

A. Romashchenko

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: razumov@bionet.nsc.ru
Россия, Novosibirsk

D. Petrovskii

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: razumov@bionet.nsc.ru
Россия, Novosibirsk

K. Kuper

G. I. Budker Institute of Nuclear Physics, Siberian Division of the Russian Academy of Sciences

Email: razumov@bionet.nsc.ru
Россия, Novosibirsk

M. Moshkin

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: razumov@bionet.nsc.ru
Россия, Novosibirsk


© Springer Science+Business Media, LLC, 2017

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах